§ BIOTECHNOLOGY
USD · Biotechnology

IONS

IONIS PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 0.41
LAST · MARKET CLOSE · OCT 05
43.54
−0.46 ▼ 1.05%PREV CLOSE · $44.00
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
OPEN 44.17HIGH 44.17LOW 43.2452W 23.95 — 86.74

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
286 increased/new, 161 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B26.20EPS (TTM)-2.47
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Fidelity Management24.6M0.1%+2%
Capital World Investors21.2M0.2%+18%
BlackRock, Inc.10.4M0.0%−2%
VANGUARD PORTFOLIO MANAGEMENT LLC7.8Mn/an/a
VANGUARD CAPITAL MANAGEMENT LLC7.1Mn/an/a
WELLINGTON MANAGEMENT GROUP LLP6.4M0.1%+2%
◇ AC INTELLIGENCE

Top institutional owners for IONS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER49.9% · 370 holders
QUALITY / COMPOUNDER34.6% · 34 holders
DEALER / BANK11.4% · 42 holders
PASSIVE / INDEX11.0% · 11 holders
SYSTEMATIC / QUANT1.8% · 11 holders
TACTICAL / MACRO1.6% · 4 holders
INCOME / DEFENSIVE1.4% · 22 holders
ACTIVIST0.3% · 1 holder
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for IONS in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES